In-Vitro Diagnostics for Cardiology and Neurology Market Size

In-vitro diagnostics for cardiology and neurology Market size was valued at USD 15.83 billion in 2023 and is set to cross USD 47.96 billion by 2036, registering more than 8.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of In-vitro diagnostics for cardiology and neurology is evaluated at USD 16.96 billion. The growth of the market can be attributed to the growing adoption of point-of-care testing devices to fuel the demand for in-vitro diagnostics tests, and increasing prevalence of chronic diseases across the globe. In 2019, approximately 18 million people in the world died from cardiovascular diseases, and about 9 million people from cancer, both of which are chronic diseases. Along with these, rising awareness levels regarding disease diagnosis, and rapidly surging geriatric population worldwide, as they are more prone to several disorders, are also expected to drive market growth in the forthcoming years. Furthermore, pharmaceutical companies are investing heavily on the development of condition-specific markers and tests, which in turn is projected to offer ample growth opportunities to the market in the near future.